Pharma Roundup: Schering-Plough Pays Missouri, 12 Pfizer Execs Announced, and More

Schering-Plough reaches settlement with Missouri -- The state's attorney general accused the firm's generics subsidiary, Warrick, of price inflation in sales to Medicaid. The settlement is valued at $31 million. [Source: Forbes]

Executive announcements at Pfizer -- Ian Reed, head of the pharmaceutical division, named the 12 executives who will be leading business units and reporting to him in Pfizer's new structure. [Source: Pharmalot]

Four CEOS talk to BusinessWeek -- Jeffrey Kindler of Pfizer, Severin Schwan of Roche, James Cornelius of BMS, and John Lechleiter of Lilly came together to discuss mergers and acquisitions, productivity, and other issues. All are relatively new to their companies, none having been appointed before 2006. [Source: BusinessWeek]